Translational progress in regenerative lung therapy

The autumn 2025 development program also marked a significant milestone in The Bridge’s translational pipeline, strengthening the connection between laboratory innovation and clinical implementation. Through coordinated experimental workflows, standardized protocols, and cross-border collaboration, the center further refined its approach to treating damaged donor lungs using advanced cellular therapies.

These efforts highlight The Bridge Lund for Life’s commitment to building scalable regenerative solutions and expanding the pool of transplantable lungs, bringing us closer to a future where more patients can benefit from life-saving lung transplantation.

Filming in the laboratory